You are here:
05 August 2014
Niger tackles its two biggest child killers with Gavi support
Life-saving pneumococcal and rotavirus vaccines are to be provided to all Niger’s children.
04 June 2014
Children's Investment Fund Foundation to invest in GAVI Alliance HPV programmes
First Ladies of Ghana and Mozambique join UK launch of End Cervical Cancer Now campaign.
23 May 2014
Developing countries back ambitious GAVI plans to help immunise 300 million children
Ghana and GAVI host successful event at World Health Assembly.
08 May 2014
African leaders pledge support for immunisation
African leaders pledge to prioritise sustainable immunisation programmes as part of continued investment in the healthy futures of children and families in their countries.
04 November 2013
Ghana to vaccinate girls against HPV with GAVI support
School girls in four districts to be immunised against leading cause of cervical cancer.
30 October 2013
How we are doing so far?
GAVI partners give a personal take on the Mid-Term Review, immunisation and the Alliance’s performance against its strategic goals
29 October 2013
Save the Children and Action launch reports at GAVI Mid-Term Review
‘Halfway there’ and ‘Donor Immunization Record’ underline civil society role in holding GAVI accountable for its performance since 2011 replenishment in London.
22 October 2013
GAVI supports Cambodia’s campaign to vaccinate children against measles and rubella
More than four million children will receive the measles-rubella vaccine over the next three months.
14 October 2013
GAVI Alliance on track to immunise a quarter of a billion children by 2015 and prevent nearly 4 million deaths
The GAVI Alliance is on track to meet its ambitious targets of supporting developing countries to immunise an additional quarter of a billion children by 2015, and preventing nearly four million deaths in the process. [Arabic] | [Chinese] | [German] | [Italian] | [Japanese] | [Korean] | [Spanish]
08 October 2013
GAVI statement on latest trial data on malaria vaccine candidate RTS,S
Latest data published by Glaxosmithkline and PATH Malaria Vaccine Initiative
© Gavi 2014
modal window here